Crescent Pharmaceutical Group operates through a network of complementary UK and global operations spanning pharmaceutical development, manufacturing, commercial operations and distribution. Together, these capabilities support medicines from development through to market, combining specialist expertise, manufacturing capacity and resilient supply infrastructure to deliver dependable medicine supply across the UK and international markets.
OUR OPERATIONAL SCALE
Crescent Pharmaceutical Group combines a broad medicines portfolio with significant development, manufacturing, regulatory and distribution capabilities. Our operational network provides the scale, infrastructure and expertise needed to support reliable medicine supply across the UK and international markets.
Granted Marketing Authorisations
0
+
Products in Active Development
0
+
Pallets of Inventory Held in the UK
0
k+
Packs Supplied Annually to the UK Market
0
M+
UK Manufacturing Facilities
0
+
Product Lines Supplied to NHS Hospitals
0
+
The Group’s principal UK pharmaceutical business, managing an extensive portfolio of generic medicines and supporting commercial, regulatory, supply and distribution activities across UK healthcare.
UK pharmaceutical manufacturing facility specialising in liquids, beta-lactam antibiotics, specials, controlled drugs, creams and gels, strengthening Crescent’s domestic manufacturing and supply capability.
Large-scale UK pharmaceutical manufacturing facility for solid dose, specials, controlled drugs and liquid medicines, supporting the continued expansion of Crescent’s UK production capability.
Specialist UK manufacturing facility for liquids, creams, gels, powders and unlicensed Specials, providing flexible production for established and niche medicines.
Crescent’s UK pharmaceutical distribution hub, providing large-scale, temperature-controlled storage and infrastructure for nationwide medicine supply.
Crescent’s global in-house pharmaceutical development and manufacturing operation, combining formulation and analytical development with established tablet and capsule manufacturing capabilities to support the Group’s growing medicines portfolio.
Crescent’s global in-house pharmaceutical development centre, supporting formulation and analytical development, technology transfer and solid-dose manufacturing.
Crescent’s European pharmaceutical operation, supporting the development, registration and commercialisation of medicines across European markets and providing a platform for the Group’s continued international expansion.
